Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
Judy C BougheyHongmei YuCatherine Lu DuganMara A PiltinLauren PostlewaitJennifer D SonKirsten K EdmistonConstantine V GodellasMarie C LeeMichael J CarrJennifer E TonnesonAngelena CrownRachel B LancasterHannah E WoriaxCheryl A EwingHarrison S ChauAnne K PattersonJasmine M WongMichael D AlvaradoRachel L YangTheresa W ChanJori B SheadeGretchen M AhrendtKelsey E LarsonKayla SwitallaTodd M TuttleJulia C TchouRoshni RaoNina TamirisaPuneet SinghRebekah E GouldAlicia TerandoCandice SauderKelly HewittAkiko ChibaLaura J EssermanRita A MukhtarPublished in: Annals of surgical oncology (2023)
Use of ALND after NAC has significantly decreased over the past decade. This is most pronounced in cN+ disease at diagnosis with an increase in the use of SLN surgery after NAC. Additionally, in pN+ disease after NAC, there has been a decrease in use of completion ALND, a practice pattern change that precedes results from clinical trials.
Keyphrases